Keywords: novacea, mds, compound, phase, ii, privately-held, biopharmaceutical

Novacea to test MDS compound in Phase II

Article | 20 January 2003

Print This

Privately-held US biopharmaceutical company Novacea has startedenrolling patients into a Phase II clinical trial of DN-101 as a treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in